Stay updated with breaking news from Janssen Research Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational, first-in-class bispecific antibody...
The startup is focused on building out strategic partnerships with pharmaceutical companies and vertically integrated healthcare companies.
The significant growth in the ambulatory surgical centers market can be credited to several factors highlighting the rising need for multispecialty outpatient surgical facilities. A primary
Atropos Health raises $33M on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions,
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.